Trial intelligence / Profile preview

DIAMOND-OCT: Sitagliptin for Vascular Healing

NCT02802644Phase 4Unknown

Sponsor
Chung-Ang University
Start
Jun 2016
Primary completion
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Chung-Ang University. Status: unknown.

02

Drugs

sitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT02802644.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02802644.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call